title: Skin toxicity after administration of low-dose cytarabine.
authors.affiliation: Department of Pediatric Oncology, Ege University Faculty of Medicine, Bornova, Izmir, Turkey.
authors.forename: M
authors.initials: M
authors.lastname: Kantar
authors.forename: N
authors.initials: N
authors.lastname: Cetingül
authors.forename: H
authors.initials: H
authors.lastname: Oniz
authors.forename: Y
authors.initials: Y
authors.lastname: Aydinok
authors.forename: K
authors.initials: K
authors.lastname: Kavakli
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D002648:Child; D003561:Cytarabine / Q000009:adverse effects*; D004893:Erythema Nodosum / Q000139:chemically induced; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D012871:Skin Diseases / Q000139:chemically induced*; D014581:Urticaria / Q000139:chemically induced
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine